{"id":"https://openalex.org/W3003143162","doi":"https://doi.org/10.1158/1535-7163.targ-19-b065","title":"Abstract B065: TANK-Binding Kinase 1 (TBK1) as a novel cancer immunotherapy target","display_name":"Abstract B065: TANK-Binding Kinase 1 (TBK1) as a novel cancer immunotherapy target","publication_year":2019,"publication_date":"2019-12-01","ids":{"openalex":"https://openalex.org/W3003143162","doi":"https://doi.org/10.1158/1535-7163.targ-19-b065","mag":"3003143162"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-19-b065","doi":"https://doi.org/10.1158/1535-7163.targ-19-b065","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-19-b065","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034793554","display_name":"Ajaykumar Vishwakarma","orcid":"https://orcid.org/0000-0003-0823-2933","observed_orcids":["https://orcid.org/0000-0003-0823-2933"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajaykumar Vishwakarma","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079433380","display_name":"Yi Sun","orcid":"https://orcid.org/0009-0003-1720-8844","observed_orcids":["https://orcid.org/0009-0003-1720-8844"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yi Sun","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024224423","display_name":"Amina Fu","orcid":"https://orcid.org/0009-0008-1256-116X","observed_orcids":["https://orcid.org/0009-0008-1256-116X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amina Fu","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041947795","display_name":"Emily J. Robitschek","orcid":"https://orcid.org/0000-0002-2771-0155","observed_orcids":["https://orcid.org/0000-0002-2771-0155"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Robitschek","raw_affiliation_strings":["2Broad Institute of Harvard and MIT, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Broad Institute of Harvard and MIT, Cambridge, MA;","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030438113","display_name":"Arvin Iracheta\u2010Vellve","orcid":"https://orcid.org/0000-0002-6635-3904","observed_orcids":["https://orcid.org/0000-0002-6635-3904"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arvin Iracheta-Vellve","raw_affiliation_strings":["2Broad Institute of Harvard and MIT, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Broad Institute of Harvard and MIT, Cambridge, MA;","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008556009","display_name":"Susanna Stinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanna Stinson","raw_affiliation_strings":["3Gilead Sciences, Foster City, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Gilead Sciences, Foster City, CA;","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002551319","display_name":"Aliasger K. Salem","orcid":"https://orcid.org/0000-0002-1923-6633","observed_orcids":["https://orcid.org/0000-0002-1923-6633"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aliasger Salem","raw_affiliation_strings":["4College of Pharmacy, University of Iowa, Iowa City, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4College of Pharmacy, University of Iowa, Iowa City, IA","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082908624","display_name":"Robert T. Manguso","orcid":"https://orcid.org/0000-0003-1336-413X","observed_orcids":["https://orcid.org/0000-0003-1336-413X"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Manguso","raw_affiliation_strings":["2Broad Institute of Harvard and MIT, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Broad Institute of Harvard and MIT, Cambridge, MA;","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033056679","display_name":"Russell William Jenkins","orcid":"https://orcid.org/0000-0001-6110-2148","observed_orcids":["https://orcid.org/0000-0001-6110-2148"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell Jenkins","raw_affiliation_strings":["1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"12_Supplement","first_page":"B065","last_page":"B065"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tbk1","display_name":"TBK1","score":0.871999979019165},{"id":"https://openalex.org/keywords/cancer-immunotherapy-targets","display_name":"cancer immunotherapy targets","score":0.8330000042915344},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.9810000061988831},{"id":"https://openalex.org/keywords/innate-immune-signaling","display_name":"innate immune signaling","score":0.75},{"id":"https://openalex.org/keywords/crispr-deletion","display_name":"CRISPR deletion","score":0.5619999766349792},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7129999995231628},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.753000020980835},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7040911912918091},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6288205981254578},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5581011772155762},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.5277850031852722},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5240975618362427},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5042368173599243},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5005595684051514},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.48384347558021545},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4564717710018158},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.42807114124298096},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29150864481925964},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13802224397659302},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12073135375976562}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-19-b065","doi":"https://doi.org/10.1158/1535-7163.targ-19-b065","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-19-b065","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3007246459","https://openalex.org/W2263980547","https://openalex.org/W4361271945","https://openalex.org/W2085972006","https://openalex.org/W3166800855","https://openalex.org/W3197188017","https://openalex.org/W4200507838","https://openalex.org/W2911915410","https://openalex.org/W2575161424","https://openalex.org/W3029432090"],"abstract_inverted_index":{"Abstract":[0],"Despite":[1,53],"the":[2,68,120,171,177,279,293,336,519],"unprecedented":[3],"success":[4],"of":[5,56,70,98,123,135,148,150,160,176,194,201,221,281,283,289,341,355,471,518],"immune":[6,38,103,109,142,233,358],"checkpoint":[7,104,359],"blockade":[8,137,302],"(ICB)":[9],"in":[10,41,46,138,219,231,272,317],"melanoma":[11],"and":[12,23,87,91,100,106,125,152,156,173,185,235,276,312,338,526],"other":[13],"cancers,":[14],"tackling":[15],"innate":[16,51,232],"(primary)":[17],"resistance":[18,101,153,299,330,356,470],"remains":[19],"a":[20,115,139,168,213,227,256,326,419,510],"major":[21,466],"challenge":[22],"robust":[24,71],"biomarkers":[25,72],"to":[26,49,73,94,102,119,145,154,157,183,271,300,328,331,357,474],"guide":[27,74,158],"treatment":[28,203,223],"are":[29,33],"lacking.":[30],"Clinical":[31],"trials":[32],"already":[34],"underway":[35],"evaluating":[36],"novel":[37,83,195,202,214,343,511],"modulatory":[39,110],"agents":[40],"combination":[42,58,344],"with":[43,306],"anti-PD-1/PD-L1":[44],"therapies":[45,61],"an":[47,79,187,237],"effort":[48],"overcome":[50,305,329],"resistance.":[52],"increasing":[54],"reports":[55],"\u2018rational\u2019":[57],"strategies,":[59],"these":[60],"remain":[62],"\u201cone":[63],"size":[64],"fits":[65],"all\u201d,":[66],"due":[67],"lack":[69],"clinical":[75,92,339],"decision-making.":[76],"There":[77],"is":[78,186,226,236],"unmet":[80],"need":[81],"for":[82,89,191,240],"approaches,":[84],"tools,":[85],"techniques,":[86],"methods":[88],"pre-clinical":[90,192,337],"use":[93],"better":[95],"understand":[96],"mechanisms":[97],"response":[99,151,180,270],"inhibitors":[105],"next-generation":[107,161],"anti-tumor":[108],"drugs.":[111],"We":[112],"have":[113,260,277],"adapted":[114],"3D":[116,318],"microfluidic":[117,319],"device":[118],"short-term":[121],"culture":[122],"murine-":[124,311],"patient-derived":[126,313],"organotypic":[127,314],"tumor":[128,141,315,472],"spheroids":[129,316],"(MDOTS/PDOTS)for":[130],"functional":[131],"ex":[132],"vivo":[133,273,413],"profiling":[134],"PD-1":[136,301,332],"model":[140,189],"microenvironment":[143],"(TIME)":[144],"facilitate":[146],"identification":[147],"mediators":[149],"ICB":[155,184],"development":[159,340],"immunotherapy":[162,197,216,258,421,513],"combinations.":[163],"The":[164],"MDOTS/PDOTS":[165],"platform":[166],"provides":[167],"window":[169],"into":[170],"complex":[172],"dynamic":[174],"events":[175],"TIME":[178],"during":[179],"(and":[181],"resistance)":[182],"ideal":[188],"system":[190],"evaluation":[193,200],"cancer":[196,215,257,420,512],"targets.":[198],"Focused":[199],"combinations":[204],"using":[205,310],"MDOTS":[206],"identified":[207,253],"TANK-binding":[208],"kinase":[209,229],"1":[210,507],"(TBK1)":[211,508],"as":[212,255,325,418,509],"target,":[217],"mirroring":[218],"vivoefficacy":[220],"this":[222,342],"approach.":[224],"TBK1":[225,254,266,290,308,324],"Ser/Thr":[228],"involved":[230],"signaling":[234],"emerging":[238],"target":[239,327,514],"anti-cancer":[241],"therapy.":[242],"Importantly,":[243],"independent":[244],"orthogonal":[245],"data":[246],"from":[247],"two":[248],"different":[249],"laboratories":[250],"has":[251],"also":[252],"target.We":[259],"confirmed":[261,297],"that":[262,298],"Tbk1":[263,284],"deletion":[264,282],"and/or":[265],"pharmacologic":[267,287,307],"inhibition":[268,288,309],"enhances":[269],"anti-PD-1":[274],"therapy,":[275],"characterized":[278],"impact":[280],"(CRISPR)":[285],"or":[286],"(Cmpd1)":[291],"on":[292,523],"tumor-immune":[294],"microenvironment.Lastly,":[295],"we":[296],"can":[303],"be":[304],"culture.":[320],"These":[321],"findings":[322],"confirm":[323],"blockade,":[333],"further":[334],"supporting":[335],"strategy.":[345],"REFERENCES":[346],"1.":[347],"Jenkins":[348],"RW,":[349],"Barbie":[350],"DA,":[351],"Flaherty":[352],"KT.":[353],"Mechanisms":[354],"inhibitors.":[360],"Br":[361],"J":[362],"Cancer.":[363],"2018;118(1):9-16.":[364],"doi:":[365,425,480],"10.1038/bjc.2017.434.":[366],"PubMed":[367,427,482],"PMID:":[368,428,483],"29319049;":[369],"PMCID:":[370],"PMC5765236.":[371],"2.":[372],"Manguso":[373],"RT,":[374],"Pope":[375],"HW,":[376,454],"Zimmer":[377],"MD,":[378],"Brown":[379,459],"FD,":[380],"Yates":[381],"KB,":[382],"Miller":[383],"BC,":[384],"Collins":[385],"NB,":[386],"Bi":[387],"K,":[388,450],"LaFleur":[389],"MW,":[390],"Juneja":[391],"VR,":[392],"Weiss":[393],"SA,":[394],"Lo":[395],"J,":[396,458],"Fisher":[397],"DE,":[398,405],"Miao":[399],"D,":[400,432,446],"Van":[401],"Allen":[402],"E,":[403],"Root":[404],"Sharpe":[406],"AH,":[407],"Doench":[408,457],"JG,":[409],"Haining":[410],"WN.":[411],"In":[412],"CRISPR":[414],"screening":[415],"identifies":[416],"Ptpn2":[417],"target.":[422],"Nature.":[423],"2017.":[424],"10.1038/nature23270.":[426],"28723893.":[429],"3.":[430],"Pan":[431],"Kobayashi":[433],"A,":[434],"Jiang":[435],"P,":[436,452],"Ferrari":[437],"de":[438],"Andrade":[439],"L,":[440],"Tay":[441],"RE,":[442],"Luoma":[443],"AM,":[444],"Tsoucas":[445],"Qiu":[447],"X,":[448],"Lim":[449],"Rao":[451],"Long":[453],"Yuan":[455],"GC,":[456],"M,":[460],"Liu":[461],"XS,":[462],"Wucherpfennig":[463],"KW.":[464],"A":[465],"chromatin":[467],"regulator":[468],"determines":[469],"cells":[473],"T":[475],"cell-mediated":[476],"killing.":[477],"Science.":[478],"2018;359(6377):770-5.":[479],"10.1126/science.aao1710.":[481],"29301958.":[484],"Citation":[485],"Format:":[486],"Ajaykumar":[487],"Vishwakarma,":[488],"Yi":[489],"Sun,":[490],"Amina":[491],"Fu,":[492],"Emily":[493],"Robitschek,":[494],"Arvin":[495],"Iracheta-Vellve,":[496],"Susanna":[497],"Stinson,":[498],"Aliasger":[499],"Salem,":[500],"Robert":[501],"Manguso,":[502],"Russell":[503],"Jenkins.":[504],"TANK-Binding":[505],"Kinase":[506],"[abstract].":[515],"In:":[516],"Proceedings":[517],"AACR-NCI-EORTC":[520],"International":[521],"Conference":[522],"Molecular":[524],"Targets":[525],"Cancer":[527,538],"Therapeutics;":[528],"2019":[529],"Oct":[530],"26-30;":[531],"Boston,":[532],"MA.":[533],"Philadelphia":[534],"(PA):":[535],"AACR;":[536],"Mol":[537],"Ther":[539],"2019;18(12":[540],"Suppl):Abstract":[541],"nr":[542],"B065.":[543],"doi:10.1158/1535-7163.TARG-19-B065":[544]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}